Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?


E2di2R_XMAA02Cl.jpgRedenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it. Sign up here!

Related Post

Redenlab contributes to position paper on advancing digital healthtechnologies for frontotemporal degeneration

  • Posted on 15 May, 2025
    MEDIA RELEASE MELBOURNE, VIC – A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap for the...
    Read more

    Redenlab announces landmark study in collaboration with Queensland Institute of Medical Research

    • Posted on 11 December, 2024
      MEDIA RELEASE Melbourne - December 2024 – Redenlab, a leader in innovative healthcare solutions, has partnered with the Queensland Institute of Medical...
      Read more

      Interview with Experts (2022) | Professor Adam Vogel

      • Posted on 2 July, 2024
        This video features an interview hosted by Global Health Youth Connect with Professor Adam Vogel called Interview with Experts.The conversation...
        Read more